Last $71.95 USD
Change Today -0.60 / -0.83%
Volume 856.5K
ALNY On Other Exchanges
Symbol
Exchange
NASDAQ GS
Frankfurt
As of 8:10 PM 09/15/14 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Charles L. Cooney Ph.D.

Member of the Scientific Advisory Board for Alnylam Biotherapeutics, Alnylam Pharmaceuticals, Inc.
AgeTotal Calculated CompensationThis person is connected to 171 board members in 15 different organizations across 19 different industries.

See Board Relationships
70--

Background*

Prof. Charles L. Cooney, also known as Charlie, Ph.D., serves as Scientific Advisor at Pronutria, Inc. Prof. Cooney co-founded Mitra Biotech Pvt Ltd. in 2008 and also serves as its Chairman of the Board. He serves as Senior Advisor of Boston Analytics, Inc. He serves as Principal of BioInformation Associates Inc. He serves as Scientific Advisor of Ironwood Pharmaceuticals Inc. He serves as Consultant of a number of biotech and pharmaceutical companies globally. He has ...

Read Full Background

Corporate Headquarters*

300 Third Street
Cambridge, Massachusetts 02142

United States

Phone: 617-551-8200
Fax: 617-551-8101

Board Members Memberships*

Former Director
Trustee
Director
Co-Founder and Chairman
Director and Scientific Advisor
1983-N/A
Former Director
1983-Present
Independent Director, Chairman of Compensation Committee and Member of Nominating & Corporate Governance Committee
1983-N/A
Independent Director, Chairman of Compensation Committee and Member of Nominating & Corporate Governance Committee
1983-N/A
Former Director
1983-Present
Director, Chairman of Compensation Committee and Member of Nominating & Corporate Governance Committee
1996-Present
Director, Member of Audit Committee, Member of Corporate Governance and Nominating Committee and Member of Compensation and Pension Committee
2001-Present
Independent & Non-Executive Director, Chairman of Risk Review Committee, Chairman of Nomination & Remuneration Committee, Chairman of Stakeholders Relationship Committee and Member of Audit Committee
2007-Present
Director
2008-Present
Director and Member of Audit Committee

Education*

MA 1967
Massachusetts Institute of Technology
PhD 1970
Massachusetts Institute of Technology
BS 1966
The University of Pennsylvania

Other Affiliations*

Annual Compensation*

There is no Annual Compensation data available.

Stock Options*

There is no Stock Options data available.

Total Compensation*

There is no Total Compensation data available.
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
ALNY:US $71.95 USD -0.60

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
George W. Hebard III, M.B.AInterim Principal Executive Officer, Interim Chief Operating Officer and Secretary
Enzon Pharmaceuticals Inc.
$428.5K
Hans G. C. P. Schikan Chief Executive Officer and Member of Management Board
Prosensa Holding N.V.
--
Mark W. Schwartz Ph.D.Chief Executive Officer and President
Galena Biopharma, Inc.
$490.0K
Mark J. Murray Ph.D.Chief Executive Officer, President and Director
Tekmira Pharmaceuticals Corporation
$377.5K
Kleanthis G. Xanthopoulos Ph.D.Chief Executive Officer, President, Principal Financial & Accounting Officer and Director
Regulus Therapeutics Inc.
$600.0K
Compensation as of Fiscal Year 2013.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact ALNYLAM PHARMACEUTICALS INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.